|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 403/14 | (2006.01) |
| (11) | Number of the document | 2178863 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08796910.1 |
| Date of filing the European patent application | 2008-07-31 | |
| (97) | Date of publication of the European application | 2010-04-28 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-24 |
| (46) | Date of publication of the claims translation | 2013-02-25 |
| (86) | Number | PCT/US2008/071696 |
| Date | 2008-07-31 |
| (87) | Number | WO 2009/020825 |
| Date | 2009-02-12 |
| (30) | Number | Date | Country code |
| 954595 P | 2007-08-08 | US |
| (72) |
PACK, Shawn, K., US
GENG, Peng, US
SMITH, Michael, J., US
HAMM, Jason, US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland Unlimited Company,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Junginių, skirtų hepatito C gydymui, sintezės būdai |
| PROCESS FOR SYNTHESIZING COMPOUNDS USEFUL FOR TREATING HEPATITIS C |
| Payment date | Validity (years) | Amount | |
| 2019-06-19 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-07-31 |